Novo Nordisk leads a GLP-1 agonist market that could surpass $150 billion by 2035. Ironically, the market is passing on the ...

From the weight-loss boom to must-have sweet treats, we discover the top 10 trends dominating food and beverage in 2025.

A large majority of older Americans feel that health insurance – including Medicare – should cover anti-obesity medications, ...

There are many claims about the benefits of microdosing weight-loss drugs, from anti-inflammatory effects to extending ...

Eli Lilly and Novo Nordisk are in a global battle for dominance in the weight loss space. BioSpace takes a look at the ...

CEO David Cordani is not convinced of the benefits of GLP-1s for weight-loss patients and said the US is the only country ...

Preclinical Data to Support Advancement Toward First-in-Human Clinical Trials SARASOTA, FL, March 26, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, ...

First-ever positive profit, entering a new era of growth and global innovation ...

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on developing first-in-class therapies for allergic and inflammatory diseases, today announced two major developments in the ...

Jenner & Block has become the latest Big Law firm to be the subject of an executive order, as President Donald Trump ...

This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your ...